Table 3.
The homocysteine levels and headache characteristics changes (after − before) in the study groups
Parameter | Vitamin Group | Placebo Group | p-value |
---|---|---|---|
Monthly Headache Frequency | -3 (-4.5 – 0.5) | -1 (-3 – 2) | 0.014* |
Headache Severity (VAS) | -1 (-2 – 0) | 0 (-1 – 1) | 0.001* |
Headache Duration (Hour) | 0 (-1 – 0.5) | 0 (-1 – 0) | 0.973 |
Headache Disability (pedMIDAS) | -4 (-8.5 – 2) | -1 (-2 – 2) | 0.002* |
Homocysteine (μmol/L) | -2.45 (-5.34 – 1.72) | 0.1 (-1.86 – 1) | 0.040* |
PedMIDAS, pediatric migraine disability assessment score; VAS-pain, visual analog scale for pain.
Statistical comparisons were done by Mann–Whitney U-test.
*Statistically significant (p<0.05).